• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Immun . Increased pulmonary pneumococcal clearance after resolution of H9N2 avian influenza virus infection in mice

tetano

Editor, Senior Moderator
Infect Immun


. 2021 Mar 15;IAI.00062-21.
doi: 10.1128/IAI.00062-21. Online ahead of print.
Increased pulmonary pneumococcal clearance after resolution of H9N2 avian influenza virus infection in mice


Jingyun Li[SUP] 1 [/SUP], Hongyan Wang[SUP] 1 [/SUP], Pengjing Lian[SUP] 1 [/SUP], Yu Bai[SUP] 1 [/SUP], Zihui Zhang[SUP] 1 [/SUP], Lihong Zhao[SUP] 1 [/SUP], Tong Xu[SUP] 2 [/SUP], Jian Qiao[SUP] 3 [/SUP]



Affiliations

Abstract

H9N2 avian influenza virus has been continuously circulating among poultry and could infect mammals, indicating that this virus is a potential pandemic strain. During influenza pandemics, secondary bacterial (particularly pneumococcal) pneumonia usually contributes to excess mortality. In the present study, we observed the dynamic effect of H9N2 virus infection on host defense against secondary pneumococcal infection in mice. BALB/c mice were intranasally inoculated with 1.2 ? 10[SUP]5[/SUP] plaque forming units (PFU) of H9N2 virus followed by 1 ? 10[SUP]6[/SUP] colony forming units of Streptococcus pneumoniae on 7, 14 or 28 days post-H9N2 infection (D.P.I.). The bacterial load, histopathology, body weight and survival were assessed after pneumococcal infection. Our results showed that H9N2 virus infection had no significant impact on host resistance to secondary pneumococcal infection on 7 D.P.I. However, H9N2 virus infection increased pulmonary pneumococcal clearance and reduced pneumococcal pneumonia-induced morbidity after secondary pneumococcal infection on 14 or 28 D.P.I., as reflected by significantly decreased bacterial loads, markedly alleviated pulmonary histopathological changes and significantly reduced weight loss in mice infected with H9N2 virus followed by S. pneumoniae compared with mice infected only with S. pneumoniae Further, the significantly decreased bacterial loads were observed when mice were previously infected with a higher dose (1.2 ? 10[SUP]6[/SUP] PFU) of H9N2 virus. Besides, similar to the results obtained in BALB/c mice, improvement in pulmonary pneumococcal clearance was also observed in C57BL/6 mice. Overall, our results showed that pulmonary pneumococcal clearance is improved after resolution of H9N2 virus infection in mice.
 
Back
Top Bottom